Skip to main content
    C

    Compass Pathways Plc (CMPS)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $8.61
    +0.80 (+10.24%)

    Market Cap: $1.22B

    Last updated: Nov 06, 2026 at 4:41 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(17/26)
    Avg Surprise
    +3.70%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$-0.53
    Range$-1.30 - $-0.09
    4 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    14 analysts
    Last 12 of 30 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$-0.53$-1.30 - $-0.09--4--
    Sep 26
    Reported Nov 3
    		$-0.31$-0.39$-0.41 - $-0.25+20.51%Beat4
    0
    1
    30d
    		+18.4%
    Jun 26
    Reported Aug 5
    		$-0.36$-0.46$-0.54 - $-0.41+21.74%Beat4
    No revisions (30d)
    		+12.2%
    Mar 26
    Reported May 13
    		$-0.30$-0.31$-0.35 - $-0.28+3.23%Beat2
    1
    1
    30d
    		+28.6%
    Dec 25
    Reported Mar 24
    		$-0.61$-0.40$-0.42 - $-0.36-52.66%Miss2
    2
    0
    30d
    		+3.7%
    Sep 25
    Reported Nov 4
    		$-0.38$-0.40$-0.41 - $-0.40+5.00%Beat2
    2
    0
    30d
    		+32.1%
    Jun 25
    Reported Jul 31
    		$-0.41$-0.37$-0.37 - $-0.37-10.81%Miss2
    2
    0
    30d
    		+26.8%
    Mar 25
    Reported May 8
    		$-0.42$-0.49$-0.67 - $-0.41+14.29%Beat5
    1
    0
    30d
    		+23.6%
    Dec 24
    Reported Feb 27
    		$-0.63$-0.63$-0.75 - $-0.56+0.00%Beat7
    1
    3
    30d
    		-18.9%
    Sep 24
    Reported Oct 31
    		$-0.56$-0.59$-0.68 - $-0.48+5.08%Beat9
    No revisions (30d)
    		+16.4%
    Jun 24
    Reported Aug 1
    		$-0.56$-0.55$-0.65 - $-0.44-1.82%Miss7
    No revisions (30d)
    		+9.7%
    Mar 24
    Reported May 8
    		$-0.55$-0.49$-0.68 - $-0.28-12.24%Miss5
    No revisions (30d)
    		+3.5%
    Dec 23
    Reported Feb 29
    		$-0.53$-0.34$-0.62 - $-0.24-55.88%Miss5
    No revisions (30d)
    		+27.4%

    Key Metrics

    Valuation
    P/E Ratio-5.46EV/EBITDAN/A
    Price/FCF-7.92xFCF Yield-12.63%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-296.50%ROIC-201.52%
    Financial Health
    Debt/Equity0.36xInterest Coverage-75.59x
    Current Ratio1.50xQuick Ratio1.50x
    Trading Statistics
    Beta2.41Avg Volume3.60M
    52-Week High$15.8752-Week Low$4.88

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$10.09
    SMA 20$10.74
    SMA 50$12.32
    SMA 200$10.43
    EMA 10$9.61
    EMA 20$10.49
    EMA 50$11.64
    EMA 200$10.64

    MACD

    Line: -1.01Signal: -0.71Hist: -0.30

    ADX

    ADX: 30.5+DI: 12.1-DI: 41.0

    Aroon & PSAR

    Aroon Up76.0
    Aroon Down84.0
    PSAR$12.11

    Bollinger Bands

    Upper Band$13.63
    Lower Band$7.85
    %B Position5380%(Upper)
    Band Width0.13

    RSI (14-Day)

    Neutral
    34.2

    Momentum Oscillators

    Stoch %K16.1
    Stoch %D17.4
    Williams %R-78.4
    ROC (10d)-23.0%
    Momentum-2.57
    CCI (20d)-145.1
    MFI (14d)27.9

    Volatility Measures

    ATR (14d)$0.91(10.5%)
    StdDev (20d)1.45
    Hist Vol124.6%(High)

    Volume Flow

    VWAP$8.43
    OBV81.0M
    AD Line-54.8M
    CMF (20d)-0.245

    Volume Metrics

    Avg Vol (20d)3.7M
    Vol Ratio1.0x
    VWMA (20d)$9.80

    Pivot Points

    R3$9.18
    R2$8.90
    R1$8.35
    Pivot Point$8.07
    S1$7.52
    S2$7.24
    S3$6.69

    Advanced Oscillators

    TSI-29.96
    Ultimate Osc36.1
    KST-187.87

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total RevenueN/A$0$0$0$0$0$0$0$0$0$0$3.68M
    Cost of RevenueN/AN/AN/A$5,991$14,909$159,869N/AN/AN/A$63,070$60,965$1.84M
    Gross ProfitN/AN/AN/A$-5,991$-14,909$-159,869N/AN/AN/A$-63,070$-60,965$1.84M
    Operating Expenses$56.44M$52.37M$42.90M$45.95M$40.54M$42.93M$49.62M$48.41M$47.90M$43.32M$38.57M$38.41M
    R&D$23.46M$29.18M$26.48M$29.91M$23.40M$30.32M$30.88M$32.14M$32.93M$29.07M$24.90M$27.14M
    SG&A$32.98M$23.20M$16.42M$16.05M$13.21M$12.61M$18.74M$16.27M$14.97M$14.25M$13.67M$11.27M
    Operating Income$-56,437,000$-52,372,000$-42,904,000$-45,952,000$-40,536,000$-42,933,000$-49,616,000$-48,414,000$-47,896,000$-43,322,000$-38,573,000$-38,405,000
    Interest Income$0$3.74M$2.42M$1.31M$1.59M$1.90M$2.39M$1.62M$1.98M$2.41M$2.26M$0
    Interest Expense$1.50M$1.48M$1.46M$1.14M$1.10M$1.15M$1.12M$1.13M$1.14M$1.11M$1.10M$1.12M
    Income Before Tax$-10,937,000$-253,463,000$91.19M$-96,612,000$-137,947,000$-38,266,000$-17,510,000$-42,309,000$-38,329,000$-37,925,000$-34,965,000$-32,138,000
    Income Tax Expense$-1,106,000$331,000$-11,000$-2,734,000$-230,000$137,000$354,000$1.02M$173,000$176,000$222,000$394,000
    Net Income$-9,831,000$-253,794,000$91.20M$-93,878,000$-137,717,000$-38,403,000$-17,864,000$-43,332,000$-38,502,000$-38,101,000$-35,187,000$-32,532,000
    EBITDA$-9,432,000$-251,980,000$92.71M$-95,469,000$-136,833,637$-36,957,000$-16,349,000$-41,127,000$-37,133,000$-36,750,000$-33,806,000$-31,014,000
    EBITN/A$-251,980,000$92.66M$-95,475,000$-136,848,637$-37,115,000$-16,386,000$-41,177,000$-37,192,000$-36,813,000$-33,867,000$-30,912,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CMPS

    CMPS Valuation and Fair Value

    P/E
    -5.5x
    P/FCF
    -7.9x
    P/B
    9.9x
    See GNG's fair value

    CMPS Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROIC
    -201.5%
    ROE
    -296.5%
    FCF yield
    -12.6%

    CMPS Competitors

    CompanyTicker
    Silence Therapeutics PLCSLN
    MannKind CorpMNKD
    Tourmaline Bio Inc.TRML
    Amphastar PAMPH
    Procept Biorobotics CorpPRCT
    Goodrx Holdings IncGDRX
    Nektar TherapeuticsNKTR
    Inhibrx Biosciences, Inc.INBX

    Sector: Healthcare

    CMPS Analyst Ratings

    Consensus
    Buy
    Analysts
    16
    Strong Buy
    3
    Buy
    12
    Hold
    1
    Sell
    0
    Strong Sell
    0

    CMPS Bull Case vs Bear Case

    Bull case

    • 93.8% of CMPS's analyst ratings are Buy or Strong Buy.

    CMPS Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    0.2%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $-0.53

    CMPS Earnings Date

    CMPS reports Mar 22, 2027, after the close. The date is estimated.

    CMPS Earnings Call

    The latest CMPS earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    CMPS ETF Holders

    GNG tracks 3 ETFs that hold CMPS. The largest weights:

    1. ARK Genomic Revolution ETF (ARKG), 2.63% of the fund
    2. iShares Biotechnology ETF (IBB), 0.09% of the fund
    3. Royce Value Trust Inc (RVT), 0.03% of the fund
    Open the ETF Stock Exposure tool for CMPS

    See insider activity

    Frequently Asked Questions About CMPS

    When does CMPS report earnings?

    Compass Pathways Plc (CMPS) is expected to report earnings on Mar 22, 2027.

    Does CMPS pay dividends?

    Compass Pathways Plc (CMPS) does not currently pay a regular dividend.

    What is CMPS's market cap?

    Compass Pathways Plc (CMPS) has a market capitalization of $1.22B with a current stock price of $8.61.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In